| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/13543784.10.7.1243 |
| P8608 | Fatcat ID | release_dcxlch2r4jhn7przxzjplkx2xq |
| P698 | PubMed publication ID | 11772248 |
| P2093 | author name string | Steer CJ | |
| Rodrigues CM | |||
| P2860 | cites work | Identification of a nuclear receptor for bile acids | Q22010058 |
| Bile acids: natural ligands for an orphan nuclear receptor | Q22010063 | ||
| The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity | Q24630723 | ||
| Structure of Bax: coregulation of dimer formation and intracellular localization | Q27628839 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity | Q28354314 | ||
| Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation | Q28373562 | ||
| Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations | Q28506809 | ||
| Caspases: enemies within | Q29547315 | ||
| The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
| Bcl-2 functions in an antioxidant pathway to prevent apoptosis | Q29620401 | ||
| Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis | Q30890236 | ||
| Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes | Q32075927 | ||
| Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition | Q32075959 | ||
| Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. | Q33834255 | ||
| Mitochondrial membrane perturbations in cholestasis. | Q33836633 | ||
| Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis | Q33910573 | ||
| An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. | Q34732527 | ||
| Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? | Q35254212 | ||
| Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes | Q35824326 | ||
| Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis | Q36288387 | ||
| Mechanisms and regulation of bile secretion | Q37253872 | ||
| A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation | Q37383640 | ||
| Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis | Q38326924 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor | Q40897197 | ||
| Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes | Q41082336 | ||
| The proto-oncogene Bcl-2 and its role in regulating apoptosis | Q41492030 | ||
| Double identity for proteins of the Bcl-2 family | Q41508318 | ||
| Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species | Q41513775 | ||
| Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids | Q41668171 | ||
| Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study | Q41916901 | ||
| Control by signaling modulators of the sorting of canalicular transporters in rat hepatocyte couplets: role of the cytoskeleton | Q42496447 | ||
| Involvement of microtubules in the swelling-induced stimulation of transcellular taurocholate transport in perfused rat liver | Q42797129 | ||
| Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding. | Q43575682 | ||
| Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis | Q44772320 | ||
| Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease | Q45291692 | ||
| Hepatic injury induced by bile salts: correlation between biochemical and morphological events | Q46245057 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 1243-1253 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Expert Opinion on Investigational Drugs | Q5421208 |
| P1476 | title | The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent | |
| P478 | volume | 10 |
| Q44982548 | A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation |
| Q40429203 | Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition |
| Q42610890 | Death pathways associated with photodynamic therapy |
| Q57113939 | High Dose and Delayed Treatment with Bile Acids Ineffective in RML Prion-Infected Mice |
| Q48405759 | Lipid peroxidation is not the primary mechanism of bilirubin-induced neurologic dysfunction in jaundiced Gunn rat pups |
| Q55020611 | N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models. |
| Q35669694 | Neuronal loss in the rostral ventromedial medulla in a rat model of neuropathic pain |
| Q38628470 | Obeticholic acid for the treatment of primary biliary cirrhosis |
| Q35730907 | Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial |
| Q90456286 | Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function |
| Q89690610 | Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study |
| Q37367051 | Quantitative Identification of Compound-Dependent On-Modules and Differential Allosteric Modules From Homologous Ischemic Networks |
| Q36972534 | Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records |
| Q37257418 | Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis |
| Q34075502 | Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. |
| Q55260793 | The role of bile acids in cellular invasiveness of gastric cancer. |
| Q38946483 | Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis |
| Q39658125 | Ursodeoxycholic acid inhibits TNFα-induced IL-8 release from monocytes |
| Q51373827 | Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study. |
Search more.